Myosteatosis and aortic calcium score on abdominal CT as prognostic markers in non-dialysis chronic kidney disease patients

• Published in: Scientific reports Vol. 14; no. 1; p. 7718
• Main Authors: Kim, Ahyun, Lee, Chul-min, Kang, Bo-Kyeong, Kim, Mimi, Choi, Jong Wook
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 02.04.2024; Nature Publishing Group; Nature Portfolio
• Subjects: 692/53; 692/699/1585; Abdomen; Aged; Aorta; Body composition; Calcium; Computed tomography; Dialysis; Hemodialysis; Humanities and Social Sciences; Humans; Kidney diseases; Kidneys; Medical prognosis; multidisciplinary; Muscle, Skeletal - pathology; Musculoskeletal system; Prognosis; Regression analysis; Renal function; Renal Insufficiency, Chronic - complications; Renal Insufficiency, Chronic - diagnostic imaging; Renal Insufficiency, Chronic - pathology; Retrospective Studies; Risk factors; Sarcopenia; Sarcopenia - diagnostic imaging; Sarcopenia - etiology; Sarcopenia - pathology; Science; Science (multidisciplinary); Skeletal muscle; Survival; Tomography, X-Ray Computed
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-024-58293-3

We aimed to examine the relationship between abdominal computed tomography (CT)-based body composition data and both renal function decline and all-cause mortality in patients with non-dialysis chronic kidney disease (CKD). This retrospective study comprised non-dialysis CKD patients who underwent consecutive unenhanced abdominal CT between January 2010 and December 2011. CT-based body composition was measured using semiautomated method that included visceral fat, subcutaneous fat, skeletal muscle area and density, and abdominal aortic calcium score (AAS). Sarcopenia and myosteatosis were defined by decreased skeletal muscle index (SMI) and decreased skeletal muscle density, respectively, each with specific cutoffs. Risk factors for CKD progression and survival were identified using logistic regression and Cox proportional hazard regression models. Survival between groups based on myosteatosis and AAS was compared using the Kaplan–Meier curve. 149 patients (median age: 70 years) were included; 79 (53.0%) patients had sarcopenia and 112 (75.2%) had myosteatosis. The median AAS was 560.9 (interquartile range: 55.7–1478.3)/m 2 . The prognostic factors for CKD progression were myosteatosis [odds ratio (OR) = 4.31, p  = 0.013] and high AAS (OR = 1.03, p  = 0.001). Skeletal muscle density [hazard ratio (HR) = 0.93, p  = 0.004] or myosteatosis (HR = 4.87, p  = 0.032) and high AAS (HR = 1.02, p  = 0.001) were independent factors for poor survival outcomes. The presence of myosteatosis and the high burden of aortic calcium were significant factors for CKD progression and survival in patients with non-dialysis CKD.